These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12160363)

  • 1. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.
    Molldrem JJ; Leifer E; Bahceci E; Saunthararajah Y; Rivera M; Dunbar C; Liu J; Nakamura R; Young NS; Barrett AJ
    Ann Intern Med; 2002 Aug; 137(3):156-63. PubMed ID: 12160363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summaries for patients. Promising therapy for bone marrow failure from myelodysplastic syndromes.
    Ann Intern Med; 2002 Aug; 137(3):I-27. PubMed ID: 12160383
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A.
    Kelaidi C; Braun T; Arana R; Marceau-Renaut A; Lazarian G; Soret J; Cereja S; Letestu R; Eclache V; Lusina D; Baran-Marszak F; Ades L; Preudhomme C; Martin A; Fenaux P; Gardin C
    Leuk Res; 2018 Aug; 71():67-74. PubMed ID: 30025278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.
    Passweg JR; Giagounidis AA; Simcock M; Aul C; Dobbelstein C; Stadler M; Ossenkoppele G; Hofmann WK; Schilling K; Tichelli A; Ganser A
    J Clin Oncol; 2011 Jan; 29(3):303-9. PubMed ID: 21149672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
    Bourgeois E; Caulier MT; Rose C; Dupriez B; Bauters F; Fenaux P
    Leukemia; 2001 Jun; 15(6):950-3. PubMed ID: 11417482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia.
    Killick SB; Mufti G; Cavenagh JD; Mijovic A; Peacock JL; Gordon-Smith EC; Bowen DT; Marsh JC
    Br J Haematol; 2003 Feb; 120(4):679-84. PubMed ID: 12588356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.
    Stadler M; Germing U; Kliche KO; Josten KM; Kuse R; Hofmann WK; Schrezenmeier H; Novotny J; Anders O; Eimermacher H; Verbeek W; Kreipe HH; Heimpel H; Aul C; Ganser A
    Leukemia; 2004 Mar; 18(3):460-5. PubMed ID: 14712285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
    Broliden PA; Dahl IM; Hast R; Johansson B; Juvonen E; Kjeldsen L; Porwit-MacDonald A; Sjoo M; Tangen JM; Uggla B; Oberg G; Hellstrom-Lindberg E
    Haematologica; 2006 May; 91(5):667-70. PubMed ID: 16670072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients.
    Breccia M; Latagliata R; Cannella L; Carmosino I; Santopietro M; Loglisci G; Federico V; Alimena G
    Leuk Lymphoma; 2010 May; 51(5):783-8. PubMed ID: 20302387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive treatment of the myelodysplastic syndrome].
    Larsen MS; Hasselbalch HC
    Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.
    Yoshimi A; Baumann I; Führer M; Bergsträsser E; Göbel U; Sykora KW; Klingebiel T; Gross-Wieltsch U; van den Heuvel-Eibrink MM; Fischer A; Nöllke P; Niemeyer C
    Haematologica; 2007 Mar; 92(3):397-400. PubMed ID: 17339190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial.
    Champlin R; Ho W; Gale RP
    N Engl J Med; 1983 Jan; 308(3):113-8. PubMed ID: 6336819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte globulin for patients with myelodysplastic syndrome.
    Molldrem JJ; Caples M; Mavroudis D; Plante M; Young NS; Barrett AJ
    Br J Haematol; 1997 Dec; 99(3):699-705. PubMed ID: 9401087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin.
    de-Medeiros CR; Ribeiro RC; Bittencourt MA; Zanis-Neto J; Pasquini R
    Braz J Med Biol Res; 2000 May; 33(5):553-8. PubMed ID: 10775887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
    Xiao L; Qi Z; Qiusheng C; Li X; Luxi S; Lingyun W
    Am J Hematol; 2012 Jan; 87(1):26-31. PubMed ID: 22038646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
    Takanashi M; Kadono Y; Tabata Y; Hibi S
    Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of lenalidomide in myelodysplastic syndromes.
    List A; Kurtin S; Roe DJ; Buresh A; Mahadevan D; Fuchs D; Rimsza L; Heaton R; Knight R; Zeldis JB
    N Engl J Med; 2005 Feb; 352(6):549-57. PubMed ID: 15703420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy for myelodysplastic syndromes: refining the indications.
    Barrett AJ; Sloand EM
    Curr Hematol Malig Rep; 2008 Jan; 3(1):23-8. PubMed ID: 20425443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.
    Yazji S; Giles FJ; Tsimberidou AM; Estey EH; Kantarjian HM; O'Brien SA; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2101-6. PubMed ID: 12931212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
    Hellström-Lindberg E; Malcovati L
    Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.